CoronaVac

CoronaVac ist ein COVID-19-Impfstoff des chinesischen Arzneimittelherstellers Sinovac Biotech. Er wurde 2020 entwickelt und wird in mehreren Ländern produziert und verimpft. Mit über 2,5 Milliarden hergestellten Dosen^[1] ist Coronavac der global am häufigsten eingesetzte COVID-Impfstoff.^[2]

↑ Cumulative number of COVID-19 vaccine doses manufactured by Sinovac Biotech between April 2021 and January 2022, Statista (2023) [1]
↑ Enny S. Paixao et al, CoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil: a test-negative case-control study, BMC Medicine 20, 146 (2022) [2]

[1] Cumulative number of COVID-19 vaccine doses manufactured by Sinovac Biotech between April 2021 and January 2022, Statista (2023) [1]

[2] Enny S. Paixao et al, CoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil: a test-negative case-control study, BMC Medicine 20, 146 (2022) [2]

[1]

[2]